 | 
|
| |
|
Titel: Vaccination mot allergier ger god symtomlindring (serie: Tema immunterapi vid astma/allergi) 2008 nr 26 sid 1938-41
|
Referenser:
1.Abramson MJ, Puy RM, Weiner JM. Allergen specific immunotherapy for asthma. The Cochranedatabase of systematic Reviews 2003, Issue 4.
2.Arvidsson MB, Löwhagen O, Rak S. Effekt of a 2-year placebo-controlled immuntotherapy on airway symptoms and medication in patients with tirch pollen allergy. J Allergy Clin Immunol 2002;109:777-83.
3.Walker S, Pajno G, Torres Lima M, Wilson D, Durham S. Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial. J Allergy Clin Immunol 2001;107:67-93.
4.Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Juller U. EAACI interest group on Isect Venom Hypersensitivity. Prevention and treatment on hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-1470.
5.Möller C, Dreborg S, Ferdousi HA, Halken S et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctiviti (The PAT-study). J Allergy Clin Immunol 2002; 109:251-6.
6.Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham S. Malling HJ, Valovirta E. Standards for Practical Allergen - Specific Immunotherapy. Allergy 2006; Supplement 82: Vol 61.
7.Allergen Immunotherapy. A practice parameter second update. J Allergy Clin Immunol Sept 2007, Vol 120 (Suppl) ;3:S25-S85.
8.Specifik Immunterapi. Rekommendationer för läkare och sjuksköterskor. Konsensus rapport från Svenska Föreningen För Allergologi. www.sffa.nu.
9.Hedlin G, Wille S, Browaldh L et al. Immunotherapy in children with allergic asthma - effects on bronchial hypperreactivity and pharmacotherapy. J Allergy Clin Immunol 1999;104:609-12.
10.Varney VA, Edwards J, Tabbah H et al. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled tiral. Clin Exp Allergy 1997;27:860-67.
11.Hedlin et al. Immunotherapy with cat and dog dander extracts. V. Effekts of 3 years of treatment. J Allergy Clin Immunol 1991;87;955-64.
12.Pichler CE, Helbling A Pichler WJ. Three years of specific immunotherapy with house-dust mite extracts in patients with rhinitis and asthma. Allergy 2001;56:301-6.
13.Pajno GB, Barberio G, De Luca F, Moratito L, Parmiani S. Prevention of new sensitisations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A sex-year follow-up study. Clin Exp Allergy 2001;31:1392-97.
14.Adkinson NF, Eggleston PA, Eney D et al. A controlled trial of immunotherapy for asthma in allergic children. New Engl J Med 1997:336:324-31.
15.Nelson H, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-51.
16.Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007: 62: 1261-69.
17.Durham SR, Walker MS Varga E-M, Jacobson MR, O'brien F et al. Long-term clinical efficacy of grass-pollen immunotherapy. New Engl J Med 1999; 341:468-75.
18.Jacobsen L, Niggermann B, Dreborg S and the PAT Investigator Group. Specific immunotherapy has long-term preventive effect on seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-48.
19.Eng PA, Borer-Reinhold M, Heijnen IAFM, Gnehm HPE. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61:198-201.
20.Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson H. Sublingual immunotherapy: A comprehensive review. J Allergy clin immunol 2006;61:185-90.
21.Dahl R, Stender A, Ra, S. Specifick immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006;61:185-90.
22.Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991; 302:265-9.
23. Des Roches A, Paradis J, Knani J et al. Immunotherapy with a standardized Dermotophagoides pteronysinus extract. V. Duration of efficacy of immunotherapy after its cessaion. Allergy 1996;51:430-3.
24.Mellerup MT, Hahn GW, Poulsen LK, Malling HJ. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 2000;30:1423-29.
25.Nielsen L, Johnsen CR, Mosbech H, Poulsen L, Malling HJ. Antihistamine premedication in specific cluster immunotherapy; a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-13.
 1938 |
 1939 |
 1940 |
 1941 |